STAT1 Activation Is Enhanced by Cisplatin and Variably Affected by EGFR Inhibition in HNSCC Cells
about
Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer.Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma.
P2860
STAT1 Activation Is Enhanced by Cisplatin and Variably Affected by EGFR Inhibition in HNSCC Cells
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
STAT1 Activation Is Enhanced b ...... EGFR Inhibition in HNSCC Cells
@ast
STAT1 Activation Is Enhanced b ...... EGFR Inhibition in HNSCC Cells
@en
type
label
STAT1 Activation Is Enhanced b ...... EGFR Inhibition in HNSCC Cells
@ast
STAT1 Activation Is Enhanced b ...... EGFR Inhibition in HNSCC Cells
@en
prefLabel
STAT1 Activation Is Enhanced b ...... EGFR Inhibition in HNSCC Cells
@ast
STAT1 Activation Is Enhanced b ...... EGFR Inhibition in HNSCC Cells
@en
P2093
P2860
P1476
STAT1 Activation Is Enhanced b ...... EGFR Inhibition in HNSCC Cells
@en
P2093
Nicole C Schmitt
Robert L Ferris
Sumita Trivedi
P2860
P304
P356
10.1158/1535-7163.MCT-15-0305
P577
2015-07-03T00:00:00Z